

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.26484307 |
| 2 | leukotriene biosynthetic process (GO:0019370) | 6.23867850 |
| 3 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.21091352 |
| 4 | cysteine metabolic process (GO:0006534) | 5.09574075 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.66688824 |
| 6 | regulation of regulatory T cell differentiation (GO:0045589) | 4.62955379 |
| 7 | leukotriene metabolic process (GO:0006691) | 4.53370645 |
| 8 | peptide catabolic process (GO:0043171) | 4.52099515 |
| 9 | DNA deamination (GO:0045006) | 4.46667545 |
| 10 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.42084007 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 3.95183778 |
| 12 | negative T cell selection (GO:0043383) | 3.89037720 |
| 13 | activated T cell proliferation (GO:0050798) | 3.78565941 |
| 14 | regulation of memory T cell differentiation (GO:0043380) | 3.74097261 |
| 15 | cellular defense response (GO:0006968) | 3.72887407 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.39219261 |
| 17 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.38247836 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.34333030 |
| 19 | membrane raft organization (GO:0031579) | 3.33426969 |
| 20 | positive T cell selection (GO:0043368) | 3.32070263 |
| 21 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.28648524 |
| 22 | negative regulation of viral genome replication (GO:0045071) | 3.26668789 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25503551 |
| 24 | protein carboxylation (GO:0018214) | 3.25503551 |
| 25 | icosanoid biosynthetic process (GO:0046456) | 3.23655188 |
| 26 | fatty acid derivative biosynthetic process (GO:1901570) | 3.23655188 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.18450741 |
| 28 | negative regulation of T cell apoptotic process (GO:0070233) | 3.16870829 |
| 29 | unsaturated fatty acid biosynthetic process (GO:0006636) | 3.13269901 |
| 30 | negative regulation of viral release from host cell (GO:1902187) | 3.03667945 |
| 31 | DNA demethylation (GO:0080111) | 3.03324096 |
| 32 | regulation of B cell differentiation (GO:0045577) | 2.95842475 |
| 33 | protein retention in ER lumen (GO:0006621) | 2.95793348 |
| 34 | regulation of histone H3-K27 methylation (GO:0061085) | 2.93990504 |
| 35 | positive regulation of macrophage differentiation (GO:0045651) | 2.89595947 |
| 36 | cell proliferation involved in metanephros development (GO:0072203) | 2.88827220 |
| 37 | T cell migration (GO:0072678) | 2.83561715 |
| 38 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.80773771 |
| 39 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.79143656 |
| 40 | disruption of cells of other organism (GO:0044364) | 2.78853024 |
| 41 | killing of cells of other organism (GO:0031640) | 2.78853024 |
| 42 | cytolysis (GO:0019835) | 2.78827423 |
| 43 | defense response to fungus (GO:0050832) | 2.77229827 |
| 44 | response to interleukin-15 (GO:0070672) | 2.76287955 |
| 45 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.74149284 |
| 46 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.72707188 |
| 47 | regulation of phospholipase A2 activity (GO:0032429) | 2.69749620 |
| 48 | cellular response to interleukin-15 (GO:0071350) | 2.69611151 |
| 49 | macrophage chemotaxis (GO:0048246) | 2.68978383 |
| 50 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.65456608 |
| 51 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.61218399 |
| 52 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.56016014 |
| 53 | positive regulation of humoral immune response (GO:0002922) | 2.53674156 |
| 54 | mannose metabolic process (GO:0006013) | 2.51518316 |
| 55 | negative regulation of viral process (GO:0048525) | 2.51240027 |
| 56 | T cell selection (GO:0045058) | 2.51066355 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.50526334 |
| 58 | DNA dealkylation (GO:0035510) | 2.48404248 |
| 59 | eosinophil chemotaxis (GO:0048245) | 2.48146904 |
| 60 | negative regulation of fatty acid transport (GO:2000192) | 2.47521053 |
| 61 | cellular extravasation (GO:0045123) | 2.47161692 |
| 62 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.44540598 |
| 63 | lymphocyte chemotaxis (GO:0048247) | 2.44243426 |
| 64 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.42917106 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 2.41700532 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.39332693 |
| 67 | negative regulation of cell killing (GO:0031342) | 2.39332693 |
| 68 | negative regulation of fibrinolysis (GO:0051918) | 2.38434530 |
| 69 | membrane protein ectodomain proteolysis (GO:0006509) | 2.37854606 |
| 70 | cell adhesion mediated by integrin (GO:0033627) | 2.36776101 |
| 71 | membrane protein proteolysis (GO:0033619) | 2.34178722 |
| 72 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.33740877 |
| 73 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.33740877 |
| 74 | extracellular matrix assembly (GO:0085029) | 2.32542981 |
| 75 | regulation of necroptotic process (GO:0060544) | 2.32136227 |
| 76 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.31919947 |
| 77 | negative regulation of stress fiber assembly (GO:0051497) | 2.31122281 |
| 78 | pentose-phosphate shunt (GO:0006098) | 2.28655724 |
| 79 | blood vessel maturation (GO:0001955) | 2.27887624 |
| 80 | regulation of viral genome replication (GO:0045069) | 2.27712837 |
| 81 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.27578744 |
| 82 | eosinophil migration (GO:0072677) | 2.25790212 |
| 83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.23959660 |
| 84 | regulation of activation of Janus kinase activity (GO:0010533) | 2.23122832 |
| 85 | myeloid dendritic cell differentiation (GO:0043011) | 2.22999794 |
| 86 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.20963918 |
| 87 | negative regulation of bone mineralization (GO:0030502) | 2.19875082 |
| 88 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.19487032 |
| 89 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.19409999 |
| 90 | carbohydrate phosphorylation (GO:0046835) | 2.18404666 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.18401732 |
| 92 | alanine transport (GO:0032328) | 2.16108978 |
| 93 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.15495180 |
| 94 | protein targeting to Golgi (GO:0000042) | 2.15324539 |
| 95 | chondroitin sulfate catabolic process (GO:0030207) | 2.15274042 |
| 96 | mesonephros development (GO:0001823) | 2.15111870 |
| 97 | sulfur compound catabolic process (GO:0044273) | 2.14152387 |
| 98 | cytidine deamination (GO:0009972) | 10.0969238 |
| 99 | cytidine metabolic process (GO:0046087) | 10.0969238 |
| 100 | cytidine catabolic process (GO:0006216) | 10.0969238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.12821501 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.63465516 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.55081697 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.05611325 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.94010721 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.79285293 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.68557035 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60955367 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.29990446 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17145591 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13515355 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09019576 |
| 13 | GATA1_19941826_ChIP-Seq_K562_Human | 2.06983154 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.06319997 |
| 15 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.97185159 |
| 16 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.93232380 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90232852 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88231479 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 1.86282781 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85928822 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85844615 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85225459 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.83821731 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.80264038 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76748862 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76363307 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74439623 |
| 28 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.70145987 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70068348 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69672786 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67947877 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60937970 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59540123 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57511126 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57125594 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.55879629 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54749856 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53468191 |
| 39 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.51848476 |
| 40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.51637418 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48796470 |
| 42 | RXR_22108803_ChIP-Seq_LS180_Human | 1.48383885 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46777954 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45448693 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45438830 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43127931 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40552501 |
| 48 | GATA2_19941826_ChIP-Seq_K562_Human | 1.40192057 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.38193360 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36849852 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33164918 |
| 52 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31224690 |
| 53 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30273917 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26316229 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25661778 |
| 56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24697839 |
| 57 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22937693 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22575993 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20419588 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20220946 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19924573 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19713334 |
| 63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19464579 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18457887 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18068472 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17561744 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17332269 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16254176 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15057872 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12852599 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08959619 |
| 72 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08959619 |
| 73 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08411683 |
| 74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07228205 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06674131 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06215779 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06070027 |
| 78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06042316 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04463982 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03498047 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03241248 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03134152 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02724314 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01328627 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00262461 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00208843 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00159112 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99894330 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98418496 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98246711 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97731734 |
| 92 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97161884 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96994228 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96762549 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96721937 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95809431 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95786698 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94843003 |
| 99 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91444333 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91262221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 4.52815917 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.39498693 |
| 3 | MP0008260_abnormal_autophagy | 3.20196086 |
| 4 | MP0005671_abnormal_response_to | 2.75813511 |
| 5 | MP0006082_CNS_inflammation | 2.52029587 |
| 6 | MP0001958_emphysema | 2.45090029 |
| 7 | MP0005451_abnormal_body_composition | 2.41830141 |
| 8 | MP0002163_abnormal_gland_morphology | 2.23838694 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.17706040 |
| 10 | MP0006054_spinal_hemorrhage | 2.12385485 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.10048960 |
| 12 | MP0002009_preneoplasia | 2.08394371 |
| 13 | MP0004272_abnormal_basement_membrane | 2.06115501 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.05455812 |
| 15 | MP0003279_aneurysm | 2.03192599 |
| 16 | MP0003091_abnormal_cell_migration | 1.96670288 |
| 17 | MP0003566_abnormal_cell_adhesion | 1.85059904 |
| 18 | MP0005379_endocrine/exocrine_gland_phen | 1.58310960 |
| 19 | MP0008004_abnormal_stomach_pH | 1.55086646 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.53861081 |
| 21 | MP0002269_muscular_atrophy | 1.53014443 |
| 22 | MP0000767_abnormal_smooth_muscle | 1.48735456 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.47880256 |
| 24 | MP0002723_abnormal_immune_serum | 1.47418454 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.47338344 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.45975856 |
| 27 | MP0000703_abnormal_thymus_morphology | 1.43344741 |
| 28 | MP0001819_abnormal_immune_cell | 1.43083177 |
| 29 | MP0005025_abnormal_response_to | 1.41300384 |
| 30 | MP0000858_altered_metastatic_potential | 1.40623209 |
| 31 | MP0001800_abnormal_humoral_immune | 1.40437992 |
| 32 | MP0001661_extended_life_span | 1.39699411 |
| 33 | MP0000716_abnormal_immune_system | 1.38754221 |
| 34 | MP0004883_abnormal_blood_vessel | 1.36975193 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.34831952 |
| 36 | MP0002419_abnormal_innate_immunity | 1.34201992 |
| 37 | MP0003448_altered_tumor_morphology | 1.33822308 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.33366684 |
| 39 | MP0009785_altered_susceptibility_to | 1.31532916 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.29589597 |
| 41 | MP0002398_abnormal_bone_marrow | 1.29008931 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.27694840 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.25831730 |
| 44 | MP0002139_abnormal_hepatobiliary_system | 1.25458888 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.25077078 |
| 46 | MP0002132_abnormal_respiratory_system | 1.24323879 |
| 47 | MP0000685_abnormal_immune_system | 1.23797427 |
| 48 | MP0004947_skin_inflammation | 1.22616858 |
| 49 | MP0009763_increased_sensitivity_to | 1.21836789 |
| 50 | MP0002722_abnormal_immune_system | 1.21489008 |
| 51 | MP0002405_respiratory_system_inflammati | 1.20807710 |
| 52 | MP0008469_abnormal_protein_level | 1.20580230 |
| 53 | MP0001756_abnormal_urination | 1.19794008 |
| 54 | MP0001790_abnormal_immune_system | 1.17893748 |
| 55 | MP0005387_immune_system_phenotype | 1.17893748 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.13386683 |
| 57 | MP0002429_abnormal_blood_cell | 1.13065359 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.12926939 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.12768586 |
| 60 | MP0003436_decreased_susceptibility_to | 1.12174732 |
| 61 | MP0002006_tumorigenesis | 1.12135195 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.11882959 |
| 63 | MP0003795_abnormal_bone_structure | 1.09830970 |
| 64 | MP0000003_abnormal_adipose_tissue | 1.09152597 |
| 65 | MP0004233_abnormal_muscle_weight | 1.08639941 |
| 66 | MP0005508_abnormal_skeleton_morphology | 1.08558452 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 1.04315390 |
| 68 | MP0000639_abnormal_adrenal_gland | 1.02532781 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02418624 |
| 70 | MP0005375_adipose_tissue_phenotype | 1.00755384 |
| 71 | MP0002971_abnormal_brown_adipose | 0.99704734 |
| 72 | MP0000566_synostosis | 0.99166938 |
| 73 | MP0005503_abnormal_tendon_morphology | 0.98949180 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97839425 |
| 75 | MP0005164_abnormal_response_to | 0.97542225 |
| 76 | MP0000733_abnormal_muscle_development | 0.95389175 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.93192660 |
| 78 | MP0010155_abnormal_intestine_physiology | 0.92928070 |
| 79 | MP0004484_altered_response_of | 0.92815947 |
| 80 | MP0002933_joint_inflammation | 0.92199336 |
| 81 | MP0000613_abnormal_salivary_gland | 0.90222884 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.89750035 |
| 83 | MP0005023_abnormal_wound_healing | 0.89653556 |
| 84 | MP0000749_muscle_degeneration | 0.88707624 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 0.85774652 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.84989519 |
| 87 | MP0005275_abnormal_skin_tensile | 0.84700787 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.83005112 |
| 89 | MP0009115_abnormal_fat_cell | 0.82525916 |
| 90 | MP0004087_abnormal_muscle_fiber | 0.82147510 |
| 91 | MP0004084_abnormal_cardiac_muscle | 0.81730267 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81567936 |
| 93 | MP0002108_abnormal_muscle_morphology | 0.81255868 |
| 94 | MP0000537_abnormal_urethra_morphology | 0.81092775 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.80419389 |
| 96 | MP0000249_abnormal_blood_vessel | 0.79228182 |
| 97 | MP0004264_abnormal_extraembryonic_tissu | 0.78930171 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.78629985 |
| 99 | MP0003075_altered_response_to | 0.76024377 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.75475587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.66882105 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.66882105 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.66882105 |
| 4 | T lymphocytopenia (HP:0005403) | 5.18695268 |
| 5 | Vertebral arch anomaly (HP:0008438) | 4.52252287 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.42110494 |
| 7 | Broad ribs (HP:0000885) | 4.11254602 |
| 8 | Aortic regurgitation (HP:0001659) | 3.86856545 |
| 9 | Broad alveolar ridges (HP:0000187) | 3.83991834 |
| 10 | J-shaped sella turcica (HP:0002680) | 3.53979368 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 3.43517432 |
| 12 | Abnormality of the lumbar spine (HP:0100712) | 3.42569463 |
| 13 | Flat acetabular roof (HP:0003180) | 3.40935248 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.33582876 |
| 15 | Carpal bone hypoplasia (HP:0001498) | 3.23843201 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.22334444 |
| 17 | Aplastic anemia (HP:0001915) | 3.11187704 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09449504 |
| 19 | Recurrent bronchitis (HP:0002837) | 2.94801114 |
| 20 | Flared iliac wings (HP:0002869) | 2.93623991 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 2.89403910 |
| 22 | Abnormality of T cells (HP:0002843) | 2.81154434 |
| 23 | Recurrent viral infections (HP:0004429) | 2.74813450 |
| 24 | Cholecystitis (HP:0001082) | 2.70790645 |
| 25 | Abnormal gallbladder physiology (HP:0012438) | 2.70790645 |
| 26 | Granulocytopenia (HP:0001913) | 2.67445845 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.67060710 |
| 28 | Thoracic kyphosis (HP:0002942) | 2.63458500 |
| 29 | Abnormality of eosinophils (HP:0001879) | 2.61426220 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.60985123 |
| 31 | Abnormality of the alveolar ridges (HP:0006477) | 2.60708611 |
| 32 | Diastasis recti (HP:0001540) | 2.60643829 |
| 33 | Thoracolumbar scoliosis (HP:0002944) | 2.59005594 |
| 34 | Reticulocytosis (HP:0001923) | 2.58960644 |
| 35 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.53791941 |
| 36 | Premature rupture of membranes (HP:0001788) | 2.53269892 |
| 37 | Slow saccadic eye movements (HP:0000514) | 2.51681898 |
| 38 | Eosinophilia (HP:0001880) | 2.50574922 |
| 39 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.48863078 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.48863078 |
| 41 | Thickened calvaria (HP:0002684) | 2.46959471 |
| 42 | Vertebral compression fractures (HP:0002953) | 2.45771689 |
| 43 | Joint hemorrhage (HP:0005261) | 2.39931713 |
| 44 | Mitral stenosis (HP:0001718) | 2.37550545 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.34780753 |
| 46 | Hypoplasia of the thymus (HP:0000778) | 2.31148645 |
| 47 | Nonimmune hydrops fetalis (HP:0001790) | 2.25769530 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25199600 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25199600 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25199600 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.25138848 |
| 52 | Deformed sella turcica (HP:0002681) | 2.23811256 |
| 53 | Protuberant abdomen (HP:0001538) | 2.18739253 |
| 54 | Pustule (HP:0200039) | 2.16130606 |
| 55 | Aortic dissection (HP:0002647) | 2.12082013 |
| 56 | Abnormality of the thoracic spine (HP:0100711) | 2.11598612 |
| 57 | Papilledema (HP:0001085) | 2.11057294 |
| 58 | Aortic aneurysm (HP:0004942) | 2.08555955 |
| 59 | Hematochezia (HP:0002573) | 2.08354821 |
| 60 | Dislocated radial head (HP:0003083) | 2.04767119 |
| 61 | Abnormality of the common coagulation pathway (HP:0010990) | 2.04744436 |
| 62 | Asymmetry of the thorax (HP:0001555) | 2.04291985 |
| 63 | Craniofacial hyperostosis (HP:0004493) | 2.02796333 |
| 64 | Severe combined immunodeficiency (HP:0004430) | 2.02028949 |
| 65 | Biconcave vertebral bodies (HP:0004586) | 1.99598162 |
| 66 | Glucose intolerance (HP:0000833) | 1.97408603 |
| 67 | Nonprogressive disorder (HP:0003680) | 1.96415859 |
| 68 | Corneal dystrophy (HP:0001131) | 1.95092349 |
| 69 | Hypoplasia of the odontoid process (HP:0003311) | 1.92772300 |
| 70 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.86964144 |
| 71 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.86740651 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 1.86740651 |
| 73 | Combined immunodeficiency (HP:0005387) | 1.86652984 |
| 74 | Genetic anticipation (HP:0003743) | 1.86570917 |
| 75 | Ectopia lentis (HP:0001083) | 1.85767303 |
| 76 | Broad palm (HP:0001169) | 1.85608681 |
| 77 | Beaking of vertebral bodies (HP:0004568) | 1.85551705 |
| 78 | Striae distensae (HP:0001065) | 1.82577857 |
| 79 | Ovoid vertebral bodies (HP:0003300) | 1.81299099 |
| 80 | Spontaneous hematomas (HP:0007420) | 1.79732954 |
| 81 | Menstrual irregularities (HP:0000858) | 1.79049504 |
| 82 | Abnormality of the radial head (HP:0003995) | 1.78755691 |
| 83 | Menorrhagia (HP:0000132) | 1.78520400 |
| 84 | Megalocornea (HP:0000485) | 1.77248945 |
| 85 | Acute hepatic failure (HP:0006554) | 1.76346435 |
| 86 | Nasolacrimal duct obstruction (HP:0000579) | 1.75855569 |
| 87 | Abnormality of the humeroradial joint (HP:0100744) | 1.73922163 |
| 88 | Purpura (HP:0000979) | 1.73854678 |
| 89 | Ureteral stenosis (HP:0000071) | 1.73853093 |
| 90 | Breech presentation (HP:0001623) | 1.72408112 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 1.72049404 |
| 92 | Leukocytosis (HP:0001974) | 1.71398622 |
| 93 | Joint swelling (HP:0001386) | 1.71219816 |
| 94 | Hemorrhage of the eye (HP:0011885) | 1.70404225 |
| 95 | Microglossia (HP:0000171) | 1.69868513 |
| 96 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68982696 |
| 97 | Cranial hyperostosis (HP:0004437) | 1.68197859 |
| 98 | Abnormality of the intrinsic pathway (HP:0010989) | 1.67751058 |
| 99 | Death in childhood (HP:0003819) | 1.67019339 |
| 100 | Abnormality of the odontoid process (HP:0003310) | 1.65845237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.79496815 |
| 2 | CDK12 | 2.94125951 |
| 3 | PRPF4B | 2.80519760 |
| 4 | RIPK4 | 2.78619193 |
| 5 | ICK | 2.76015347 |
| 6 | STK38 | 2.43764652 |
| 7 | WNK4 | 2.32519275 |
| 8 | MAP4K1 | 2.28106384 |
| 9 | FGFR4 | 2.22394214 |
| 10 | MAP3K6 | 2.20564076 |
| 11 | MAP2K7 | 2.06199498 |
| 12 | ITK | 2.03056948 |
| 13 | DYRK3 | 1.95820910 |
| 14 | RIPK1 | 1.95563226 |
| 15 | WNK1 | 1.93600527 |
| 16 | BMPR2 | 1.86679368 |
| 17 | TTN | 1.77962290 |
| 18 | PIK3CA | 1.73629825 |
| 19 | CAMKK2 | 1.63461698 |
| 20 | MAP4K2 | 1.50553165 |
| 21 | JAK3 | 1.42290809 |
| 22 | NEK9 | 1.40161657 |
| 23 | TYRO3 | 1.34502860 |
| 24 | LATS1 | 1.31013180 |
| 25 | MAPKAPK3 | 1.27269397 |
| 26 | FES | 1.25701076 |
| 27 | RPS6KA4 | 1.25375399 |
| 28 | FGFR3 | 1.22532183 |
| 29 | MAP3K2 | 1.21903389 |
| 30 | HIPK2 | 1.19587671 |
| 31 | MAP3K7 | 1.16760373 |
| 32 | CDC42BPA | 1.14910869 |
| 33 | RET | 1.12448221 |
| 34 | TNK2 | 1.10798099 |
| 35 | SGK3 | 1.10658045 |
| 36 | EEF2K | 1.08716280 |
| 37 | KDR | 1.07250559 |
| 38 | TRIB3 | 1.06126060 |
| 39 | PTK2B | 1.04084091 |
| 40 | CAMK4 | 1.00819573 |
| 41 | MAPK12 | 0.99333519 |
| 42 | KIT | 0.99190670 |
| 43 | EPHB1 | 0.95038921 |
| 44 | JAK1 | 0.93892025 |
| 45 | TGFBR2 | 0.91258589 |
| 46 | MAP2K3 | 0.90916480 |
| 47 | TYK2 | 0.89167435 |
| 48 | ERN1 | 0.88819061 |
| 49 | NLK | 0.88715112 |
| 50 | FGFR1 | 0.88060759 |
| 51 | ZAP70 | 0.84072242 |
| 52 | SGK223 | 0.84055282 |
| 53 | SGK494 | 0.84055282 |
| 54 | DYRK1B | 0.81004273 |
| 55 | SGK2 | 0.80183066 |
| 56 | LCK | 0.79807238 |
| 57 | MAPK11 | 0.79465764 |
| 58 | CSK | 0.78556994 |
| 59 | AKT2 | 0.75518857 |
| 60 | BLK | 0.75356311 |
| 61 | OBSCN | 0.75155297 |
| 62 | BTK | 0.74575178 |
| 63 | BCKDK | 0.73838030 |
| 64 | RPS6KA6 | 0.69599213 |
| 65 | LYN | 0.67559849 |
| 66 | RPS6KL1 | 0.65310384 |
| 67 | RPS6KC1 | 0.65310384 |
| 68 | NEK6 | 0.64858613 |
| 69 | PDK1 | 0.64462147 |
| 70 | EIF2AK3 | 0.63525418 |
| 71 | MYLK | 0.63061384 |
| 72 | SIK1 | 0.63018247 |
| 73 | CDK6 | 0.62818083 |
| 74 | PDPK1 | 0.62177201 |
| 75 | IRAK2 | 0.61474285 |
| 76 | TAOK3 | 0.60777494 |
| 77 | PKN2 | 0.60296960 |
| 78 | MAP3K5 | 0.60111064 |
| 79 | PDGFRA | 0.58400595 |
| 80 | FYN | 0.56288607 |
| 81 | MTOR | 0.55383086 |
| 82 | MAP3K1 | 0.54862922 |
| 83 | KSR2 | 0.52698247 |
| 84 | TIE1 | 0.52165328 |
| 85 | MAPK7 | 0.51400562 |
| 86 | SYK | 0.50487268 |
| 87 | CAMKK1 | 0.50329905 |
| 88 | YES1 | 0.48475074 |
| 89 | IRAK1 | 0.48004821 |
| 90 | PIM1 | 0.47742649 |
| 91 | CDK8 | 0.46139218 |
| 92 | MELK | 0.45955258 |
| 93 | MAPKAPK2 | 0.45857590 |
| 94 | PDGFRB | 0.45467926 |
| 95 | MAP3K14 | 0.44371196 |
| 96 | PAK2 | 0.43535783 |
| 97 | TRPM7 | 0.41736269 |
| 98 | RPS6KB1 | 0.41057420 |
| 99 | JAK2 | 0.40779281 |
| 100 | MARK3 | 0.40054077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.32238099 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.00293255 |
| 3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.50716002 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.41722317 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.35205042 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24650964 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.05791636 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95156242 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.91398999 |
| 10 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.84491708 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81538445 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77296415 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77249843 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59714318 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57219301 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55032291 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46070007 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.44266565 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.39582512 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.35088853 |
| 21 | ABC transporters_Homo sapiens_hsa02010 | 1.29798091 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29496738 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.27802345 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.22121739 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20504751 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.15370753 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.13307881 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11586735 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11492042 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08593341 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.08252231 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.05737917 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95878567 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94324313 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93162837 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92480087 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89441529 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 0.89207942 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88467122 |
| 40 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88344023 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86415283 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86123957 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.85971377 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85057337 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84712686 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83010897 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81137528 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 0.79786670 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77867192 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76711550 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76147191 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75347968 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73924205 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.73566569 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70955843 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.68884703 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68202456 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68045553 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65694663 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63992311 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.63902571 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63490860 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63447881 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62730564 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.61758358 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.61050034 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.59659780 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.59142552 |
| 69 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59094792 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57250969 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55121169 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54890632 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53443294 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52711911 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52524665 |
| 76 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51128842 |
| 77 | Allograft rejection_Homo sapiens_hsa05330 | 0.50920837 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.50062832 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50023774 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49639141 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48355495 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47623245 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45837356 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45628257 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44637031 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44505535 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44458266 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43139699 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43122062 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42264902 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42243509 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41671828 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40549113 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40269829 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40168253 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38584386 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37857433 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37588601 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.37527148 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.37098114 |

